Omkar Pharmachem MD, chairman, board of directors and AGM
BSE: 532167Chemicals & PetrochemicalsSmall Cap
Share price at the BSE close on 23 Oct 2026. Previous close ₹7.59.
- Under BSE's graded surveillance, stage II, on the list for 22 Oct 2026. The exchange puts a share here when its price has moved unusually, and trading in it carries extra conditions.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹7.29 Cr3,900th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. The filing of 13 Aug 2026
- 85.6
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. The filing of 30 May 2026
- 0.2
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it. The filing of 13 Aug 2026
- 0.4%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet. The filing of 13 Aug 2026
- 0.3%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. The filing of 30 May 2026
- 0.00
- Volume, BSEVolume. Shares traded on the last trading day.
- 100
Omkar Pharmachem board of directors
At the end of the quarter to Jun 2026, as the company filed it; changes since are in its announcements.
- Managing directorBhawani S Goyal
4 directors2 independent1 executive1 non-executive
- Bhawani S Goyal · Managing directorExecutive · joined Feb 2020 · reappointed Sep 2024 · 1 listed board
- Parminder SharmaNon-executive · joined Nov 2003 · 1 listed board · 2 committee seats, 1 as chair
- Surjeet KaurIndependent · joined Jun 2025 · 12 months as independent · 1 listed board · 1 as independent · 3 committee seats, 1 as chair
- Anupam Kumar MishraIndependent · joined Aug 2025 · 10 months as independent · 1 listed board · 1 as independent · 2 committee seats
An independent director has no business or family tie to the company, its promoters or its managers beyond the seat. Listed boards counts the boards of listed companies the director sits on, this one included, and "as independent" how many of those seats are independent ones. Committee seats are audit and stakeholder committee seats across those companies. Months as independent is filed for independent directors only, whose terms the rules cap. Disqualified is the company's own mark that a director may not serve under company law.
2 directors who left
- Janak Raj Sharma, left 12 Feb 2026: Tenure Completion
- Mamta Pachauri, left 28 Jun 2025: Tenure Completion
Committees and meetings
Who sits on each, and how often they met.Board meeting notices and outcomes
Board
- 30 May 20264 of 4 present2 independent · 42 days in between
- 17 Apr 20264 of 4 present2 independent · 20 days in between
- 27 Mar 20264 of 4 present2 independent · 40 days in between
- 14 Feb 20264 of 4 present2 independent · 17 days in between
1 earlier meeting
- 27 Jan 20265 of 5 present3 independent
Audit Committee
Chair Surjeet Kaur
Parminder Sharma, Anupam Kumar Mishra
- 30 May 20263 of 3 present2 independent · 104 days in between
- 14 Feb 20263 of 3 present2 independent · 17 days in between
- 27 Jan 20263 of 3 present2 independent
Nomination and remuneration committee
Chair Surjeet Kaur
Parminder Sharma, Anupam Kumar Mishra
- 30 May 20263 of 3 present2 independent · 63 days in between
- 27 Mar 20263 of 3 present2 independent · 58 days in between
- 27 Jan 20263 of 3 present2 independent
Stakeholders Relationship Committee
Chair Parminder Sharma
Surjeet Kaur, Anupam Kumar Mishra
- 30 May 20263 of 3 present2 independent · 63 days in between
- 27 Mar 20263 of 3 present2 independent · 58 days in between
- 27 Jan 20263 of 3 present2 independent
Meetings in the quarter filed and the one before it. The days in between are as the company files them, neither meeting's day counted; the rules allow at most 120. A quorum is the least number of members who must attend for the meeting to decide anything.
Statutory auditor
Named in the results for the quarter to Mar 2026.
- Dipal R Shah & Co.Peer-review certificate valid to Aug 2026
A statutory auditor checks the company's accounts and signs its results. Peer review is the accountants' institute's check of an audit firm's own work, which a listed company's auditor must hold a valid certificate of.
Omkar Pharmachem AGM and shareholder votes
Each resolution, how the votes went, and how institutions voted apart from the promoters. A postal ballot is a vote by post or online, held without a meeting.Omkar Pharmachem share news and announcements
Annual general meeting, 30 Sep 2026
3,785 shareholders on the register on 23 Sep 2026; present: 0 promoters and 16 others; votes counted by MAULIK A. BHAVSAR / MAULIK BHAVSAR & ASSOCIATES.The company's voting result (opens in a new tab)
To receive, consider and adopt the Audited Financial Statements of the Company i.e. audited Balance Sheet as at 31st March, 2026, Statement of Profit and Loss, Statement of Change in Equity and Cash Flow Statement for the year ended on that date together with the Reports of the Directors and Auditors thereon.MoreLess
Ordinary100.00% for0.00% againstAgainst: promoters 0.00% · institutions 0.00% · other public 0.00%
Turnout: all 19.23% · promoters 0.00% · institutions 0.00% · other public 19.24%
- To appoint a Director in place of Mr. Parminder Sharma (DIN- 00176300), who retires by rotation at this Annual General Meeting and being eligible has offered himself for re-appointment.Ordinary100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.00%
Turnout: all 19.23% · promoters 0.00% · institutions 0.00% · other public 19.24%
- To Consider and approve Material Related Party TransactionsOrdinary100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.00%
Turnout: all 19.23% · promoters 0.00% · institutions 0.00% · other public 19.24%
For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.
Investor complaints and compliance
Quarter by quarter.
Investor complaints received and resolved, the company's own count
- Received
- Resolved
Open at the quarter's end
- The board is made up as the listing rules require
- Yes
- The board has a regular chairperson
- No
- The company has a risk management committee
- No
- The chair is related to the managing director
- No
- The filing has a part on fines and penalties
- No
- The filing has a part on tax disputes
- No
- There was a cyber security incident in the quarter
- No
The company's own answers in its filing.